Otrexup: payments to doctors
Payments that named Otrexup as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $328K
- Providers
- 5,062
- Transactions
- 13,562
- Average per transaction
- $24
The per-transaction average — $24 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,062 providers the average total is $65, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Antares Pharma, Inc. | $248,364 | 75.6% |
| Assertio Therapeutics, Inc. | $73,621 | 22.4% |
| Otter Pharmaceuticals, LLC | $6,510 | 2.0% |